Request Trial
18 December 2024NewsAmericasRajiv Nayar, President, HTD Biosystems | Chuck Sholtz, Vice President, Intellectual Property, Nutcracker Therapeutics | Benjamin Pelletier, Partner, Haynes & Boone

WATCH: What are the latest challenges in patenting biologics, biosimilars, and bispecific antibodies?

Speakers from HTD Biosystems, Nutcracker Therapeutics, and Haynes & Boone examine the evolving patent landscape for biologics, biosimilars, and bispecific antibodies, sharing practical strategies and jurisdiction-specific insights.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
CureVac targets Moderna with 10-patent suit over Spikevax
28 April 2026   BioNTech’s former rival—now part of its company—is seeking to assert its mRNA portfolio against Moderna in a new suit over modifications to the highly fought-over molecule.
Americas
Amneal acquires biopharma ahead of $300bn patent wave
23 April 2026   The US pharma giant is spending up to $1 billion to build an end-to-end biosimilar platform and is counting on a decade of expiring biologic patents to make it pay off.
Americas
Health tech firm sues Nvidia-backed rival over ‘brazen’ theft
23 April 2026   Plaintiff alleges that a $6 billion rival probed its records system via a long-term customer, using confidential information to develop its product in the behavioural health tech space.


Editor's picks

Penile implant maker’s $17m trade secret award unravels
Americas
Penile implant maker’s $17m trade secret award unravels
20 April 2026

Editor's picks

Americas
Penile implant maker’s $17m trade secret award unravels
20 April 2026
Europe
European patent offices raise fees
2 April 2026
Americas
Argentina’s patent reset: Why pharma can no longer ignore Latin America's second-largest market
1 April 2026
Europe
WIPR debuts Global In-House Elite 2026
26 March 2026
Biotechnology
mRNA litigation: Who’s winning, who’s filing, and what’s next
25 March 2026
Americas
Masimo convinces judge that Apple took secrets—but it’s not enough
19 March 2026

More features

Blow for Masimo’s fight with Apple as case against US Customs dismissed
Ligand buys biotech in $739m cash deal with litigation sweetener
CureVac targets Moderna with 10-patent suit over Spikevax
Safeguarding critical IP in a high-risk era: WIPR Trade Secrets West 2026
EU court under pressure to define SPC limits in patent row
Amneal acquires biopharma ahead of $300bn patent wave
Health tech firm sues Nvidia-backed rival over ‘brazen’ theft
Squires refuses to resurrect HydraFacial patent review